Wolverine Trading’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-13,000
| Closed | -$104K | – | 7351 |
|
|
2021
Q2 | $104K | Buy |
+13,000
| New | +$111K | ﹤0.01% | 5397 |
|
|
2020
Q1 | – | Sell |
-50,100
| Closed | -$1.02M | – | 5585 |
|
|
2019
Q4 | $1.02M | Buy |
50,100
+17,400
| +53% | +$293K | ﹤0.01% | 2390 |
|
|
2019
Q3 | $455K | Buy |
32,700
+14,000
| +75% | +$166K | ﹤0.01% | 2737 |
|
|
2019
Q2 | $230K | Buy |
18,700
+8,600
| +85% | +$99.2K | ﹤0.01% | 3561 |
|
|
2019
Q1 | $126K | Sell |
10,100
-33,300
| -77% | -$445K | ﹤0.01% | 4056 |
|
|
2018
Q4 | $516K | Buy |
+43,400
| New | +$680K | ﹤0.01% | 2601 |
|
|
2018
Q3 | – | Sell |
-18,300
| Closed | -$410K | – | 6228 |
|
|
2018
Q2 | $410K | Hold |
18,300
| – | – | ﹤0.01% | 3349 |
|
|
2018
Q1 | $410K | Sell |
18,300
-2,400
| -12% | -$58.6K | ﹤0.01% | 3349 |
|
|
2017
Q4 | $518K | Buy |
20,700
+3,700
| +22% | +$90.6K | ﹤0.01% | 2955 |
|
|
2017
Q3 | $411K | Buy |
17,000
+2,500
| +17% | +$58.8K | ﹤0.01% | 2858 |
|
|
2017
Q2 | $298K | Sell |
14,500
-4,400
| -23% | -$91.6K | ﹤0.01% | 3049 |
|
|
2017
Q1 | $512K | Buy |
+18,900
| New | +$386K | ﹤0.01% | 2358 |
|
Wolverine Trading's FLXN Position: Q4 2019 in Review
Wolverine Trading sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2019, closing a stake of 18,460 shares — an estimated $311K sold.
Wolverine Trading first reported a position in FLXN in Q1 2017 and held it in 8 quarters. The position peaked at $422K in Q4 2018. 133 funds tracked by Wall St. Rank hold FLXN as of Q4 2019.
- Wolverine Trading reported no remaining Flexion Therapeutics, Inc. position as of Q4 2019 after selling out during the quarter.
- Wolverine Trading sold 18,460 Flexion Therapeutics, Inc. shares in Q4 2019, an estimated $311K.
- Wolverine Trading first reported a position in Flexion Therapeutics, Inc. in Q1 2017 and held it in 8 quarters.
- Wolverine Trading's Flexion Therapeutics, Inc. position peaked at $422K in Q4 2018.
- 133 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2019.
Based on Wolverine Trading's 13F filing for Q4 2019, filed 12 Feb 2020.